Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697840 | SCV000525668 | likely benign | not provided | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002521696 | SCV000637577 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-11-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001525509 | SCV001735645 | likely benign | Cardiomyopathy | 2020-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348195 | SCV002653204 | likely benign | Cardiovascular phenotype | 2018-11-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502538 | SCV002808442 | likely benign | Arrhythmogenic right ventricular dysplasia 2; Catecholaminergic polymorphic ventricular tachycardia 1; Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | 2021-07-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000419 | SCV004820189 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-10-02 | criteria provided, single submitter | clinical testing |